Cilostazol

Generic name: Pronounced as (sil oh' sta zol)
Brand names
  • Pletal®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 09/15/2015

Medications similar to cilostazol caused an increased risk of death in patients with congestive heart failure (condition in which the heart is unable to pump enough blood to the other parts of the body). Tell your doctor if you have or have ever had congestive heart failure. Your doctor will probably tell you not to take cilostazol.

Talk to your doctor about the risks of taking cilostazol.

Cilostazol is used to reduce the symptoms of intermittent claudication (pain in the legs that worsens when walking and improves when resting that is caused by narrowing of the blood vessels that supply blood to the legs). Cilostazol is in a class of medications called platelet-aggregation inhibitors (antiplatelet medications). It works by improving blood flow to the legs.

Cilostazol comes as a tablet to take by mouth. It is usually taken twice a day, at least 30 minutes before or 2 hours after breakfast and dinner. Take cilostazol at around the same times every day. Follow the directions on the prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take cilostazol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Cilostazol controls the symptoms of intermittent claudication but does not cure it. Although you may notice improvements in 2 to 4 weeks, it may take up to 12 weeks before you notice the full benefit (increased walking distance) of cilostazol. Continue taking cilostazol even if you feel well. Do not stop taking cilostazol without talking to your doctor.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking cilostazol,

  • tell your doctor and pharmacist if you are allergic to cilostazol, any other medications, or any of the ingredients in cilostazol. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants (''blood thinners'') such as warfarin (Coumadin); aspirin; antifungal medications such as fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); antiplatelet medications such as clopidogrel (Plavix), prasugrel (Effient), and ticlopidine (Ticlid); clarithromycin (Biaxin); diltiazem (Cardizem, Dilacor, Tiazac, others); erythromycin (E-mycin, Ery-Tab, others); fluoxetine (Prozac); fluvoxamine (Luvox); nefazadone; omeprazole (Prilosec); and sertraline (Zoloft). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have bleeding ulcers (sores in the lining of the stomach or small intestine that are bleeding), bleeding in the brain, bleeding from any other part of your body, a low number of platelets in your blood, or any other condition that causes severe bleeding. Your doctor will probably tell you not to take cilostazol.

  • tell your doctor if you have or have ever had heart, kidney, or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking cilostazol, call your doctor.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Cilostazol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • diarrhea

    • dizziness

    • heartburn

    • nausea

    • stomach pain

    • muscle pain

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

    • fast or irregular heartbeat

    • unusual bleeding or bruising

    • swelling of the arms, hands, feet, ankles, or lower legs

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • severe headache

  • dizziness

  • fainting

  • diarrhea

  • fast or irregular heartbeat

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Cilostazol can be decreased when combined with Moxifloxacin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Cilostazol can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Cilostazol can be decreased when it is combined with Leflunomide.
Delavirdine Delavirdine The serum concentration of Cilostazol can be increased when it is combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Cilostazol can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Cilostazol can be decreased when combined with Atorvastatin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Cilostazol.
Anagrelide Anagrelide The risk or severity of congestive heart failure, bleeding, hypotension, and Tachycardia can be increased when Anagrelide is combined with Cilostazol.
Clopidogrel Clopidogrel Clopidogrel may increase the antiplatelet activities of Cilostazol.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Cilostazol can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Cilostazol can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate The serum concentration of Cilostazol can be increased when it is combined with Fenofibrate.
Guanfacine Guanfacine Guanfacine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Cilostazol may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine The metabolism of Cilostazol can be decreased when combined with Methylergometrine.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Olsalazine Olsalazine The risk or severity of bleeding can be increased when Olsalazine is combined with Cilostazol.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Acebutolol.
Potassium Potassium Potassium may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Ranitidine Ranitidine The metabolism of Cilostazol can be decreased when combined with Ranitidine.
Reserpine Reserpine The metabolism of Cilostazol can be increased when combined with Reserpine.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Tacrolimus Tacrolimus The metabolism of Cilostazol can be decreased when combined with Tacrolimus.
Tizanidine Tizanidine The metabolism of Cilostazol can be decreased when combined with Tizanidine.
Triamcinolone Triamcinolone The metabolism of Cilostazol can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The metabolism of Cilostazol can be decreased when combined with Zolmitriptan.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Cilostazol.
Fluconazole Injection Fluconazole Injection The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Cilostazol can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Cilostazol can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Cilostazol can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Cilostazol can be increased when combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The metabolism of Cilostazol can be decreased when combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Cilostazol can be decreased when combined with Metronidazole.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Cilostazol may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Zidovudine.
Altretamine Altretamine The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Cilostazol.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Cilostazol can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Granisetron.
Torsemide Torsemide Torasemide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The serum concentration of Cilostazol can be increased when it is combined with Olanzapine.
Alosetron Alosetron The metabolism of Cilostazol can be decreased when combined with Alosetron.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dofetilide.
Entacapone Entacapone The metabolism of Cilostazol can be decreased when combined with Entacapone.
Hydroxychloroquine Hydroxychloroquine The metabolism of Cilostazol can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam The risk or severity of bleeding can be increased when Meloxicam is combined with Cilostazol.
Oxcarbazepine Oxcarbazepine The serum concentration of Cilostazol can be increased when it is combined with Oxcarbazepine.
Pantoprazole Pantoprazole The serum concentration of Cilostazol can be increased when it is combined with Pantoprazole.
Telmisartan Telmisartan The serum concentration of Cilostazol can be increased when it is combined with Telmisartan.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Anakinra Anakinra The metabolism of Cilostazol can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Desloratadine.
Linezolid Linezolid The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Cilostazol.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Cilostazol.
Trimipramine Trimipramine The metabolism of Cilostazol can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Cilostazol can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Cilostazol.
Modafinil Modafinil The serum concentration of Cilostazol can be increased when it is combined with Modafinil.
Perindopril Perindopril Perindopril may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Cilostazol.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Cilostazol.
Dutasteride Dutasteride The metabolism of Cilostazol can be decreased when combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Cilostazol can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of bleeding can be increased when Epirubicin is combined with Cilostazol.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The serum concentration of Cilostazol can be increased when it is combined with Escitalopram.
Zonisamide Zonisamide The serum concentration of Cilostazol can be increased when it is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Cilostazol can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Cilostazol.
Atazanavir Atazanavir The metabolism of Cilostazol can be decreased when combined with Atazanavir.
Almotriptan Almotriptan Almotriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Eletriptan Eletriptan The metabolism of Cilostazol can be decreased when combined with Eletriptan.
Mefloquine Mefloquine The metabolism of Cilostazol can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Cilostazol can be decreased when combined with Rosuvastatin.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cilostazol.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Cilostazol.
Aprepitant Aprepitant The serum concentration of Cilostazol can be increased when it is combined with Aprepitant.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Cilostazol can be decreased when combined with Interferon beta-1a.
Memantine Memantine The serum concentration of Cilostazol can be increased when it is combined with Memantine.
Tegaserod Tegaserod The metabolism of Cilostazol can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Frovatriptan Frovatriptan The metabolism of Cilostazol can be decreased when combined with Frovatriptan.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Gemifloxacin.
Progesterone Progesterone The serum concentration of Cilostazol can be increased when it is combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Cilostazol.
Infliximab Injection Infliximab Injection The metabolism of Cilostazol can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Cilostazol.
Duloxetine Duloxetine The metabolism of Cilostazol can be decreased when combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Cilostazol can be decreased when combined with Norethisterone.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Trospium Trospium The metabolism of Cilostazol can be decreased when combined with Trospium.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Cilostazol can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Cilostazol can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Solifenacin.
Valganciclovir Valganciclovir Cilostazol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The serum concentration of Cilostazol can be increased when it is combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Cilostazol.
Entecavir Entecavir The metabolism of Cilostazol can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Cilostazol can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Cilostazol can be increased when it is combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Cilostazol.
Isocarboxazid Isocarboxazid The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Cilostazol.
Ramelteon Ramelteon The metabolism of Cilostazol can be decreased when combined with Ramelteon.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Cilostazol.
Fentanyl Fentanyl The metabolism of Cilostazol can be decreased when combined with Fentanyl.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Cilostazol.
Deferasirox Deferasirox The serum concentration of Cilostazol can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Cilostazol can be increased when combined with Phenylephrine.
Tipranavir Tipranavir Tipranavir may increase the antiplatelet activities of Cilostazol.
Felbamate Felbamate The serum concentration of Cilostazol can be increased when it is combined with Felbamate.
Ranolazine Ranolazine The metabolism of Ranolazine can be decreased when combined with Cilostazol.
Abatacept Injection Abatacept Injection The metabolism of Cilostazol can be increased when combined with Abatacept.
Rasagiline Rasagiline The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Cilostazol.
Imatinib Imatinib The metabolism of Cilostazol can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin Cilostazol may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Cilostazol may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The serum concentration of Cilostazol can be increased when it is combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Cilostazol.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Paliperidone.
Bortezomib Bortezomib The serum concentration of Cilostazol can be increased when it is combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Cilostazol can be increased when combined with Insulin glulisine.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Oxaliplatin.
Posaconazole Posaconazole The metabolism of Cilostazol can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Cilostazol can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Rituximab.
Bismuth Subsalicylate Bismuth Subsalicylate The risk or severity of bleeding can be increased when Cilostazol is combined with Bismuth subsalicylate.
Darunavir Darunavir The metabolism of Cilostazol can be decreased when combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection Cilostazol may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The risk or severity of Tachycardia can be increased when Cilostazol is combined with Lisdexamfetamine.
Nabilone Nabilone The risk or severity of Tachycardia can be increased when Nabilone is combined with Cilostazol.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Vorinostat.
Sorafenib Sorafenib The serum concentration of Cilostazol can be increased when it is combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Cilostazol can be decreased when combined with Sunitinib.
Dronabinol Dronabinol The risk or severity of Tachycardia can be increased when Dronabinol is combined with Cilostazol.
Lapatinib Lapatinib The metabolism of Cilostazol can be decreased when combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Levocetirizine.
Pegaptanib Injection Pegaptanib Injection Cilostazol may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib Dasatinib may increase the anticoagulant activities of Cilostazol.
Mexiletine Mexiletine The metabolism of Cilostazol can be decreased when combined with Mexiletine.
Omega-3 Fatty Acids Omega-3 Fatty Acids Omega-3 fatty acids may increase the antiplatelet activities of Cilostazol.
Armodafinil Armodafinil The serum concentration of Cilostazol can be increased when it is combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Cilostazol.
Nelarabine Injection Nelarabine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Nelarabine.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Cilostazol can be decreased when combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Toremifene.
Bexarotene Bexarotene The risk or severity of bleeding can be increased when Cilostazol is combined with Bexarotene.
Budesonide Budesonide The metabolism of Cilostazol can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The serum concentration of Cilostazol can be increased when it is combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Decitabine.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Doripenem Injection Doripenem Injection Cilostazol may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The serum concentration of Cilostazol can be increased when it is combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Cilostazol can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Cilostazol can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Cilostazol.
Tretinoin Tretinoin The metabolism of Cilostazol can be decreased when combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Cilostazol.
Pilocarpine Pilocarpine The metabolism of Cilostazol can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Cilostazol.
Certolizumab Injection Certolizumab Injection The metabolism of Cilostazol can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The metabolism of Cilostazol can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Cilostazol can be decreased when combined with Praziquantel.
Methylnaltrexone Injection Methylnaltrexone Injection Cilostazol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of bleeding can be increased when Cilostazol is combined with Alemtuzumab.
Midazolam Midazolam The metabolism of Cilostazol can be decreased when combined with Midazolam.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Cilostazol.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Cilostazol is combined with Ibritumomab tiuxetan.
Milnacipran Milnacipran The metabolism of Cilostazol can be decreased when combined with Milnacipran.
Plerixafor Injection Plerixafor Injection Cilostazol may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Cilostazol may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Degarelix.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Betaxolol.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Cilostazol is combined with Prasugrel.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Cilostazol.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The metabolism of Cilostazol can be decreased when combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Cilostazol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Saxagliptin Saxagliptin Cilostazol may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Romidepsin.
Tapentadol Tapentadol The metabolism of Cilostazol can be decreased when combined with Tapentadol.
Topotecan Topotecan The metabolism of Cilostazol can be decreased when combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Cilostazol can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Cilostazol can be decreased when combined with Pazopanib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Asenapine.
Albendazole Albendazole The metabolism of Cilostazol can be decreased when combined with Albendazole.
Levonorgestrel Levonorgestrel The metabolism of Cilostazol can be decreased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Cilostazol.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Cilostazol is combined with Dabigatran.
Tocilizumab Injection Tocilizumab Injection The metabolism of Cilostazol can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Cilostazol may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Cilostazol.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Cilostazol can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Cilostazol can be decreased when combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Cilostazol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Cilostazol can be decreased when combined with Aldesleukin.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Cilostazol.
Busulfan Injection Busulfan Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Busulfan.
Roflumilast Roflumilast Cilostazol may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin Linagliptin The metabolism of Cilostazol can be decreased when combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Cilostazol can be decreased when combined with Rilpivirine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cilostazol can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The serum concentration of Cilostazol can be increased when it is combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Triptorelin.
Rivaroxaban Rivaroxaban Cilostazol may increase the anticoagulant activities of Rivaroxaban.
Ticagrelor Ticagrelor The metabolism of Cilostazol can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Cilostazol can be decreased when combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib Cilostazol may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Vandetanib.
Clobazam Clobazam The metabolism of Cilostazol can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Cilostazol can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The serum concentration of Cilostazol can be increased when it is combined with Vismodegib.
Ivacaftor Ivacaftor The metabolism of Cilostazol can be decreased when combined with Ivacaftor.
Deferiprone Deferiprone Cilostazol may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Cilostazol.
Crizotinib Crizotinib The metabolism of Cilostazol can be decreased when combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Cilostazol can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Cilostazol can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Cilostazol.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Fondaparinux.
Carfilzomib Injection Carfilzomib Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Cilostazol is combined with Iloprost.
Enzalutamide Enzalutamide Cilostazol may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Cilostazol.
Regorafenib Regorafenib The metabolism of Cilostazol can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Cilostazol can be decreased when combined with Bosutinib.
Teriflunomide Teriflunomide The serum concentration of Cilostazol can be decreased when it is combined with Teriflunomide.
Teduglutide Injection Teduglutide Injection Cilostazol may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Bedaquiline.
Icosapent Ethyl Icosapent Ethyl Cilostazol may increase the antiplatelet activities of Icosapent ethyl.
Tofacitinib Tofacitinib The risk or severity of bleeding can be increased when Cilostazol is combined with Tofacitinib.
Alogliptin Alogliptin Cilostazol may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Cilostazol.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Cilostazol.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Cilostazol can be decreased when combined with Trastuzumab emtansine.
Apixaban Apixaban The risk or severity of adverse effects can be increased when Cilostazol is combined with Apixaban.
Canagliflozin Canagliflozin Cilostazol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Cilostazol can be decreased when combined with Ospemifene.
Trametinib Trametinib Cilostazol may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Levomilnacipran may increase the antiplatelet activities of Cilostazol.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Vortioxetine Vortioxetine Cilostazol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Cilostazol.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Ibrutinib is combined with Cilostazol.
Lomitapide Lomitapide The metabolism of Cilostazol can be decreased when combined with Lomitapide.
Ketorolac Injection Ketorolac Injection The risk or severity of bleeding can be increased when Ketorolac is combined with Cilostazol.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Cilostazol is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Cilostazol can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Cilostazol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Cilostazol can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Cilostazol can be increased when combined with Apremilast.
Droxidopa Droxidopa Cilostazol may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Cilostazol can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Cilostazol can be decreased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The serum concentration of Cilostazol can be increased when it is combined with Eslicarbazepine.
Belinostat Injection Belinostat Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Cilostazol can be decreased when combined with Idelalisib.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Oritavancin Injection Oritavancin Injection The serum concentration of Cilostazol can be increased when it is combined with Oritavancin.
Vorapaxar Vorapaxar The risk or severity of bleeding can be increased when Cilostazol is combined with Vorapaxar.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Cilostazol is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Cilostazol can be decreased when combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Cilostazol can be decreased when combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Blinatumomab.
Methamphetamine Methamphetamine Cilostazol may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Cilostazol.
Riociguat Riociguat Cilostazol may increase the hypotensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection The metabolism of Cilostazol can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Cilostazol.
Secukinumab Injection Secukinumab Injection The metabolism of Cilostazol can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Cilostazol.
Palbociclib Palbociclib The metabolism of Cilostazol can be decreased when combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Cilostazol can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The serum concentration of Cilostazol can be increased when it is combined with Lenvatinib.
Naloxegol Naloxegol The serum concentration of Cilostazol can be increased when it is combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Cilostazol can be decreased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The metabolism of Cilostazol can be decreased when combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection The risk or severity of adverse effects can be increased when Cilostazol is combined with Deoxycholic acid.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ivabradine.
Amiloride Amiloride Amiloride may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Cilostazol can be decreased when combined with Isavuconazonium.
Macitentan Macitentan Cilostazol may decrease the excretion rate of Macitentan which could result in a higher serum level.
Rolapitant Rolapitant The metabolism of Cilostazol can be decreased when combined with Rolapitant.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Cilostazol.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Cilostazol.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Cilostazol.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Cilostazol.
Penicillin G Procaine Injection Penicillin G Procaine Injection Cilostazol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Cilostazol can be increased when combined with Insulin degludec.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Cilostazol.
Osimertinib Osimertinib The metabolism of Cilostazol can be decreased when combined with Osimertinib.
Ixazomib Ixazomib Cilostazol may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Cilostazol may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Cilostazol can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Cilostazol can be decreased when combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection Cilostazol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The metabolism of Cilostazol can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The metabolism of Cilostazol can be decreased when combined with Cobicistat.
Midodrine Midodrine The risk or severity of Tachycardia can be increased when Midodrine is combined with Cilostazol.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Cilostazol is combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Cilostazol can be decreased when combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The serum concentration of Cilostazol can be increased when it is combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Cilostazol may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib Ribociclib The metabolism of Cilostazol can be decreased when combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Cilostazol can be decreased when combined with Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Deutetrabenazine.
Valbenazine Valbenazine Cilostazol may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The metabolism of Cilostazol can be increased when combined with Deflazacort.
Safinamide Safinamide The serum concentration of Cilostazol can be increased when it is combined with Safinamide.
Naldemedine Naldemedine Cilostazol may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The metabolism of Cilostazol can be decreased when combined with Sarilumab.
Midostaurin Midostaurin The serum concentration of Cilostazol can be increased when it is combined with Midostaurin.
Enasidenib Enasidenib The serum concentration of Cilostazol can be increased when it is combined with Enasidenib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Cilostazol can be decreased when combined with Fosaprepitant.
Benznidazole Benznidazole Cilostazol may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Cilostazol.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Delafloxacin.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Cilostazol is combined with Betrixaban.
Acalabrutinib Acalabrutinib The metabolism of Cilostazol can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Gemtuzumab ozogamicin.
Letermovir Letermovir The metabolism of Cilostazol can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection The serum concentration of Cilostazol can be increased when it is combined with Buprenorphine.
Apalutamide Apalutamide Cilostazol may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Penicillamine Penicillamine The risk or severity of bleeding can be increased when Cilostazol is combined with Penicillamine.
Fostamatinib Fostamatinib The metabolism of Cilostazol can be decreased when combined with Fostamatinib.
Baricitinib Baricitinib Cilostazol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Cilostazol.
Plazomicin Injection Plazomicin Injection Cilostazol may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Cilostazol can be decreased when combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Cilostazol.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Cilostazol.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Cilostazol.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Cilostazol.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Cilostazol.
Dacomitinib Dacomitinib The metabolism of Cilostazol can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The serum concentration of Cilostazol can be increased when it is combined with Stiripentol.
Gilteritinib Gilteritinib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Cilostazol.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Cilostazol.
Rifamycin Rifamycin The serum concentration of Cilostazol can be increased when it is combined with Rifamycin.
Prucalopride Prucalopride Cilostazol may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Cilostazol can be increased when combined with Emapalumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection Cilostazol may increase the antiplatelet activities of Caplacizumab.
Esomeprazole Injection Esomeprazole Injection The serum concentration of Cilostazol can be increased when it is combined with Esomeprazole.
Alpelisib Alpelisib The metabolism of Cilostazol can be decreased when combined with Alpelisib.
Cladribine Cladribine The risk or severity of bleeding can be increased when Cilostazol is combined with Cladribine.
Solriamfetol Solriamfetol The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Cilostazol.
Triclabendazole Triclabendazole The serum concentration of Cilostazol can be increased when it is combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Cilostazol.
Pitolisant Pitolisant The serum concentration of Cilostazol can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Cilostazol can be decreased when combined with Fedratinib.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Cilostazol.
Phenytoin Injection Phenytoin Injection The metabolism of Cilostazol can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Cilostazol can be increased when combined with Fosphenytoin.
Cenobamate Cenobamate The metabolism of Cilostazol can be decreased when combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Cilostazol.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Cilostazol.
Remdesivir Injection Remdesivir Injection The metabolism of Cilostazol can be decreased when combined with Remdesivir.
Capmatinib Capmatinib The metabolism of Cilostazol can be decreased when combined with Capmatinib.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Cilostazol.
Fenfluramine Fenfluramine The metabolism of Cilostazol can be decreased when combined with Fenfluramine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Fostemsavir.
Octreotide Octreotide The metabolism of Cilostazol can be decreased when combined with Octreotide.
Pralsetinib Pralsetinib The metabolism of Cilostazol can be decreased when combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Cilostazol can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Cilostazol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) Vitamin E may increase the antiplatelet activities of Cilostazol.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Theophylline Theophylline The metabolism of Cilostazol can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen The risk or severity of bleeding can be increased when Fenoprofen is combined with Cilostazol.
Indomethacin Indomethacin The serum concentration of Cilostazol can be increased when it is combined with Indomethacin.
Mefenamic Acid Mefenamic Acid The risk or severity of bleeding can be increased when Mefenamic acid is combined with Cilostazol.
Naproxen Naproxen The risk or severity of bleeding can be increased when Naproxen is combined with Cilostazol.
Tolmetin Tolmetin The risk or severity of bleeding can be increased when Tolmetin is combined with Cilostazol.
Sulindac Sulindac The risk or severity of bleeding can be increased when Sulindac is combined with Cilostazol.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Cilostazol.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Hydroxyurea Hydroxyurea The metabolism of Cilostazol can be decreased when combined with Hydroxyurea.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Phenobarbital Phenobarbital The metabolism of Cilostazol can be increased when combined with Phenobarbital.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Primidone Primidone The metabolism of Cilostazol can be increased when combined with Primidone.
Methsuximide Methsuximide The serum concentration of Cilostazol can be increased when it is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Cilostazol.
Chlorpromazine Chlorpromazine The metabolism of Cilostazol can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The serum concentration of Cilostazol can be increased when it is combined with Diazepam.
Oxazepam Oxazepam Oxazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Flurazepam Flurazepam Flurazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Carmustine Carmustine The metabolism of Cilostazol can be decreased when combined with Carmustine.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Cilostazol.
Codeine Codeine Codeine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Bromocriptine Bromocriptine The metabolism of Cilostazol can be decreased when combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Cilostazol.
Tranylcypromine Tranylcypromine The serum concentration of Cilostazol can be increased when it is combined with Tranylcypromine.
Phenelzine Phenelzine The serum concentration of Cilostazol can be increased when it is combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Cilostazol.
Tetracycline Tetracycline The metabolism of Cilostazol can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of bleeding can be increased when Cilostazol is combined with Tioguanine.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Prochlorperazine.
Thioridazine Thioridazine The metabolism of Cilostazol can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine The metabolism of Cilostazol can be decreased when combined with Trifluoperazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Dapsone Dapsone The metabolism of Cilostazol can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Oxycodone Oxycodone The metabolism of Cilostazol can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Cilostazol can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Cilostazol can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cilostazol.
Maprotiline Maprotiline The metabolism of Cilostazol can be decreased when combined with Maprotiline.
Ibuprofen Ibuprofen The risk or severity of bleeding can be increased when Ibuprofen is combined with Cilostazol.
Trihexyphenidyl Trihexyphenidyl The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Cilostazol.
Orphenadrine Orphenadrine The metabolism of Cilostazol can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Cilostazol can be decreased when combined with Perphenazine.
Azathioprine Azathioprine The metabolism of Cilostazol can be decreased when combined with Azathioprine.
Fluphenazine Fluphenazine The metabolism of Cilostazol can be decreased when combined with Fluphenazine.
Phentermine Phentermine The risk or severity of Tachycardia can be increased when Phentermine is combined with Cilostazol.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Amoxapine Amoxapine The metabolism of Cilostazol can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of bleeding can be increased when Sulfasalazine is combined with Cilostazol.
Hydrocortisone Hydrocortisone The metabolism of Cilostazol can be decreased when combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of bleeding can be increased when Cilostazol is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Cilostazol can be decreased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of bleeding can be increased when Cilostazol is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of bleeding can be increased when Cilostazol is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of bleeding can be increased when Cilostazol is combined with Dactinomycin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Carbamazepine Carbamazepine The serum concentration of Cilostazol can be increased when it is combined with Carbamazepine.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clonidine Clonidine The metabolism of Cilostazol can be decreased when combined with Clonidine.
Hydralazine Hydralazine The metabolism of Cilostazol can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The serum concentration of Cilostazol can be increased when it is combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Cilostazol can be increased when it is combined with Warfarin.
Clonazepam Clonazepam Clonazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Loperamide Loperamide The metabolism of Cilostazol can be decreased when combined with Loperamide.
Promethazine Promethazine The metabolism of Cilostazol can be decreased when combined with Promethazine.
Meclofenamate Meclofenamate The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Cilostazol.
Daunorubicin Daunorubicin The metabolism of Cilostazol can be decreased when combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Cilostazol can be increased when combined with Griseofulvin.
Digoxin Digoxin Cilostazol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine The metabolism of Cilostazol can be decreased when combined with Chloroquine.
Quinine Quinine The serum concentration of Cilostazol can be increased when it is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Cilostazol.
Triamterene Triamterene The metabolism of Cilostazol can be decreased when combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone Sulfinpyrazone may increase the antiplatelet activities of Cilostazol.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Cilostazol.
Secobarbital Secobarbital The metabolism of Cilostazol can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Cilostazol can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline The serum concentration of Cilostazol can be increased when it is combined with Amitriptyline.
Imipramine Imipramine The serum concentration of Cilostazol can be increased when it is combined with Imipramine.
Probenecid Probenecid The serum concentration of Cilostazol can be increased when it is combined with Probenecid.
Quinidine Quinidine The metabolism of Cilostazol can be decreased when combined with Quinidine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Cilostazol.
Isoniazid Isoniazid The serum concentration of Cilostazol can be increased when it is combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Rifampin Rifampin The metabolism of Cilostazol can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Disopyramide.
Valproic Acid Valproic Acid The serum concentration of Cilostazol can be increased when it is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Cilostazol can be decreased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of bleeding can be increased when Cilostazol is combined with Mitomycin.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Methimazole Methimazole The serum concentration of Cilostazol can be increased when it is combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of bleeding can be increased when Cilostazol is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Dextromethorphan Dextromethorphan The metabolism of Cilostazol can be decreased when combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cilostazol can be decreased when combined with Cyclobenzaprine.
Niacin Niacin The metabolism of Cilostazol can be decreased when combined with Niacin.
Baclofen Baclofen Baclofen may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Cilostazol.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Cilostazol.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Cilostazol.
Meclizine Meclizine The metabolism of Cilostazol can be decreased when combined with Meclizine.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Chlorzoxazone Chlorzoxazone The metabolism of Cilostazol can be decreased when combined with Chlorzoxazone.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Danazol Danazol The metabolism of Cilostazol can be decreased when combined with Danazol.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Cilostazol.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Propranolol.
Pseudoephedrine Pseudoephedrine The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Cilostazol.
Nortriptyline Nortriptyline The metabolism of Cilostazol can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection The metabolism of Cilostazol can be decreased when combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of bleeding can be increased when Cilostazol is combined with Mercaptopurine.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Nadolol Nadolol Cilostazol may decrease the excretion rate of Nadolol which could result in a higher serum level.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Cilostazol.
Flavoxate Flavoxate Flavoxate may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Fluorouracil.
Colchicine Colchicine The metabolism of Cilostazol can be decreased when combined with Colchicine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Cilostazol can be decreased when combined with Dacarbazine.
Acetazolamide Acetazolamide The metabolism of Cilostazol can be decreased when combined with Acetazolamide.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Ketoconazole Ketoconazole The serum concentration of Cilostazol can be increased when it is combined with Ketoconazole.
Pyrantel Pyrantel Cilostazol may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Thiotepa.
Vincristine Injection Vincristine Injection The metabolism of Cilostazol can be decreased when combined with Vincristine.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Cilostazol is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of Tachycardia can be increased when Cilostazol is combined with Isoxsuprine.
Vinblastine Vinblastine The metabolism of Cilostazol can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Cilostazol can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Cilostazol.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Cilostazol.
Aspirin Aspirin Acetylsalicylic acid may increase the antiplatelet activities of Cilostazol.
Salsalate Salsalate The risk or severity of bleeding can be increased when Salsalate is combined with Cilostazol.
Chlorambucil Chlorambucil The risk or severity of bleeding can be increased when Cilostazol is combined with Chlorambucil.
Alprazolam Alprazolam Alprazolam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Triazolam Triazolam Triazolam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Dicyclomine Dicyclomine Dicyclomine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cilostazol.
Propantheline Propantheline Propantheline may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Diltiazem Diltiazem The metabolism of Cilostazol can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Cilostazol can be decreased when combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Cilostazol.
Verapamil Verapamil The metabolism of Cilostazol can be decreased when combined with Verapamil.
Atenolol Atenolol The metabolism of Cilostazol can be decreased when combined with Atenolol.
Pindolol Pindolol Pindolol may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Cilostazol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal The risk or severity of bleeding can be increased when Diflunisal is combined with Cilostazol.
Piroxicam Piroxicam The risk or severity of bleeding can be increased when Piroxicam is combined with Cilostazol.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin Streptozocin The metabolism of Cilostazol can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Cilostazol can be decreased when combined with Etoposide.
Glyburide Glyburide The metabolism of Cilostazol can be decreased when combined with Glyburide.
Glipizide Glipizide Glipizide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Indapamide Indapamide Indapamide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The metabolism of Cilostazol can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the antiplatelet activities of Cilostazol.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Labetalol Labetalol The metabolism of Cilostazol can be decreased when combined with Labetalol.
Auranofin Auranofin Auranofin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Leuprolide.
Gemfibrozil Gemfibrozil The serum concentration of Cilostazol can be increased when it is combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Cilostazol can be decreased when combined with Guanabenz.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of bleeding can be increased when Ketoprofen is combined with Cilostazol.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Pimozide Pimozide The metabolism of Cilostazol can be decreased when combined with Pimozide.
Flurbiprofen Flurbiprofen The risk or severity of bleeding can be increased when Flurbiprofen is combined with Cilostazol.
Amiodarone Amiodarone The metabolism of Cilostazol can be decreased when combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Lovastatin Lovastatin The metabolism of Cilostazol can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Cilostazol can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine The risk or severity of bleeding can be increased when Mesalazine is combined with Cilostazol.
Diclofenac Diclofenac The risk or severity of bleeding can be increased when Diclofenac is combined with Cilostazol.
Fluoxetine Fluoxetine The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Cilostazol can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The serum concentration of Cilostazol can be increased when it is combined with Clozapine.
Estazolam Estazolam Cilostazol may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The risk or severity of bleeding can be increased when Cilostazol is combined with Idarubicin.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ofloxacin.
Didanosine Didanosine Didanosine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clarithromycin Clarithromycin The metabolism of Cilostazol can be decreased when combined with Clarithromycin.
Etodolac Etodolac The risk or severity of bleeding can be increased when Etodolac is combined with Cilostazol.
Felodipine Felodipine The metabolism of Cilostazol can be decreased when combined with Felodipine.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of bleeding can be increased when Nabumetone is combined with Cilostazol.
Simvastatin Simvastatin The metabolism of Cilostazol can be decreased when combined with Simvastatin.
Teniposide Injection Teniposide Injection The metabolism of Cilostazol can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Cilostazol can be decreased when combined with Itraconazole.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Oxaprozin Oxaprozin The risk or severity of bleeding can be increased when Oxaprozin is combined with Cilostazol.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Cilostazol.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Cilostazol can be decreased when combined with Zolpidem.
Doxazosin Doxazosin The metabolism of Cilostazol can be decreased when combined with Doxazosin.
Isradipine Isradipine The metabolism of Cilostazol can be decreased when combined with Isradipine.
Omeprazole Omeprazole The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.
Cisapride Cisapride The metabolism of Cilostazol can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The serum concentration of Cilostazol can be increased when it is combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Cilostazol can be decreased when combined with Venlafaxine.
Fluvoxamine Fluvoxamine The serum concentration of Cilostazol can be increased when it is combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Cilostazol can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Cilostazol.
Losartan Losartan The serum concentration of Cilostazol can be increased when it is combined with Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Tramadol Tramadol Tramadol may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Vinorelbine Injection Vinorelbine Injection The metabolism of Cilostazol can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Cilostazol.
Lansoprazole Lansoprazole The serum concentration of Cilostazol can be increased when it is combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Cilostazol can be decreased when combined with Ifosfamide.
Nicardipine Nicardipine The serum concentration of Cilostazol can be increased when it is combined with Nicardipine.
Bupropion Bupropion The metabolism of Cilostazol can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The serum concentration of Cilostazol can be increased when it is combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Cilostazol can be decreased when combined with Saquinavir.
Metformin Metformin Metformin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Dalteparin.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Riluzole Riluzole The metabolism of Cilostazol can be decreased when combined with Riluzole.
Acarbose Acarbose Acarbose may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Indinavir Indinavir The metabolism of Cilostazol can be decreased when combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Cilostazol can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Cilostazol can be decreased when combined with Docetaxel.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clomipramine Clomipramine The serum concentration of Cilostazol can be increased when it is combined with Clomipramine.
Zafirlukast Zafirlukast The serum concentration of Cilostazol can be increased when it is combined with Zafirlukast.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Mirtazapine Mirtazapine The metabolism of Cilostazol can be decreased when combined with Mirtazapine.
Topiramate Topiramate The serum concentration of Cilostazol can be increased when it is combined with Topiramate.
Zileuton Zileuton The metabolism of Cilostazol can be decreased when combined with Zileuton.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Cilostazol can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Donepezil Donepezil The metabolism of Cilostazol can be decreased when combined with Donepezil.
Nelfinavir Nelfinavir The metabolism of Cilostazol can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Azithromycin.
Carvedilol Carvedilol The metabolism of Cilostazol can be decreased when combined with Carvedilol.
Nilutamide Nilutamide The serum concentration of Cilostazol can be increased when it is combined with Nilutamide.
Flutamide Flutamide The metabolism of Cilostazol can be decreased when combined with Flutamide.
Selegiline Selegiline The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Cilostazol.
Bicalutamide Bicalutamide The serum concentration of Cilostazol can be increased when it is combined with Bicalutamide.
Sertraline Sertraline The serum concentration of Cilostazol can be increased when it is combined with Sertraline.
Propafenone Propafenone The metabolism of Cilostazol can be decreased when combined with Propafenone.
Letrozole Letrozole The serum concentration of Cilostazol can be increased when it is combined with Letrozole.
Raloxifene Raloxifene The metabolism of Cilostazol can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Cilostazol can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Cilostazol.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Cilostazol.
Paroxetine Paroxetine The serum concentration of Cilostazol can be increased when it is combined with Paroxetine.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Citalopram Citalopram The serum concentration of Cilostazol can be increased when it is combined with Citalopram.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Efavirenz Efavirenz The serum concentration of Cilostazol can be increased when it is combined with Efavirenz.
Abacavir Abacavir Abacavir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Sildenafil Sildenafil The serum concentration of Cilostazol can be increased when it is combined with Sildenafil.
Celecoxib Celecoxib The metabolism of Cilostazol can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Cilostazol can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Cilostazol.
Thalidomide Thalidomide The serum concentration of Cilostazol can be increased when it is combined with Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Balsalazide Balsalazide The risk or severity of bleeding can be increased when Balsalazide is combined with Cilostazol.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Cilostazol.
Rabeprazole Rabeprazole The serum concentration of Cilostazol can be increased when it is combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Cilostazol can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists